New therapeutic developments for the treatment of fungal infections | 32nd ICC

This keynote lecture by Prof. Monica Slavin (Peter MacCallum Cancer Centre & Royal Melbourne Hospital, Australia) was presented at the 32nd International Congress of Antimicrobial Chemotherapy (ICC) in Perth, Australia.

Dr Slavin discusses the following:
1. Need for new antifungals
2. New treatment options in clinical trials: focussing on rezafungin, ibrexafungerp, fosmanogepix and olorofim
3. Update on azoles
4. Other advances
5. Conclusion and future directions

Subscribe to ISAC's YouTube Channel to watch other excellent plenary / keynote lectures as they are uploaded.

Visit www.ISAC.world for more information about ISAC and how to join.

Disclaimer
The webinars / lectures provided by the International Society of Antimicrobial Chemotherapy (ISAC) are for informational purposes only. No material contained herein is intended to be a substitute for professional medical advice, diagnosis, treatment or national / local guidelines.
The opinions expressed in a webinar are those of the author(s) only and may not necessarily represent the views of ISAC. Where links are provided to other sites and resources of third parties, these links are provided for your information only. ISAC neither endorses not accepts responsibility for the contents of those sites or resources.